Skip to main content
Top
Published in: Pediatric Nephrology 5/2008

01-05-2008 | Original Article

Role of the Teflon deposit in the recurrence of vesicoureteral reflux

Authors: Zsolt Oberritter, Reka Somogyi, Zsolt Juhasz, Andrew B. Pinter

Published in: Pediatric Nephrology | Issue 5/2008

Login to get access

Abstract

A relationship between the Teflon deposit, visible with ultrasound, and long-term success of subureteric Teflon injection (STING) treatment was investigated. The study included only those patients with primary vesicoureteral reflux (VUR), in whom the reflux had disappeared and the Teflon deposits were visible 6 weeks following STING treatment. Cessation of VUR was proven by voiding cysto-urethrography (VCUG) in 99 patients (143 ureters). Average follow-up time was 9 (4–12) years. Patients were divided into two groups: group I, deposits visible with ultrasound [deposit (+)], and group II, no visible deposits at the end of the follow-up period [deposit (−)]. Reflux recurrence, the occurrence of urinary tract infection (UTI), and pyelonephritis were investigated, and technetium scintigraphy scans were examined. The deposit (+) group included 43 patients (65 ureters), and the deposit (−) group contained 56 patients (78 ureters). In the deposit (+) group there were no recurrences of VUR; however, 17 recurrences were found in the deposit (−) group (P < 0.05). Dimercaptosuccinic acid (DMSA) scintigraphy scans and occurrence of UTI showed significant difference between the groups (P < 0.05). A close relationship was found between the disappearance of the Teflon deposit and the recurrence of VUR. Disappearance of the Teflon deposit and repeated bacteriuria is a warning sign of the recurrence of VUR; therefore, VCUG might be warranted for these patients.
Literature
1.
go back to reference Puri P, O’Donell B (1987) Endoscopic correction of grades IV and V primary vesicoureteric reflux: six to 30 months follow-up in 42 ureters. J Pediatr Surg 22:1087–1091CrossRef Puri P, O’Donell B (1987) Endoscopic correction of grades IV and V primary vesicoureteric reflux: six to 30 months follow-up in 42 ureters. J Pediatr Surg 22:1087–1091CrossRef
2.
go back to reference O’Donell B, Puri P (1986) Endoscopic correction of primary vesicoureteric reflux: results in 94 ureters. Br Med J (Clin Res Ed) 293:1404–1406CrossRef O’Donell B, Puri P (1986) Endoscopic correction of primary vesicoureteric reflux: results in 94 ureters. Br Med J (Clin Res Ed) 293:1404–1406CrossRef
3.
go back to reference O’Donnell B, Puri P (1986) Endoscopic correction of primary vesicoureteric reflux. Br J Urol 58:601–604CrossRef O’Donnell B, Puri P (1986) Endoscopic correction of primary vesicoureteric reflux. Br J Urol 58:601–604CrossRef
4.
go back to reference Puri P (1990) Endoscopic correction of primary vesicoureteric reflux by subureteric injection of polytetrafluoroethylene. Lancet 335:1320–1322CrossRef Puri P (1990) Endoscopic correction of primary vesicoureteric reflux by subureteric injection of polytetrafluoroethylene. Lancet 335:1320–1322CrossRef
5.
go back to reference Puri P, Nina GK, Suranc R (1995) Subureteric Teflon injection (STING). Eur Urol 27:71–75CrossRef Puri P, Nina GK, Suranc R (1995) Subureteric Teflon injection (STING). Eur Urol 27:71–75CrossRef
6.
go back to reference Puri P, Granata C (1998) Multicenter survey of endoscopic treatment of vesicoureteral reflux using polytetrafluoroethylene. J Urol 160:1007–1011CrossRef Puri P, Granata C (1998) Multicenter survey of endoscopic treatment of vesicoureteral reflux using polytetrafluoroethylene. J Urol 160:1007–1011CrossRef
7.
go back to reference Chertin B, Colhoun E, Velayudham M, Puri P (2002) Endoscopic treatment of vesicoureteral reflux: 11–17 years of follow-up. J Urol 167:1443–1445CrossRef Chertin B, Colhoun E, Velayudham M, Puri P (2002) Endoscopic treatment of vesicoureteral reflux: 11–17 years of follow-up. J Urol 167:1443–1445CrossRef
8.
go back to reference Puri P (1995) Ten-year experience with subureteric Teflon (polytetrafluoroethylene) injection (STING) in the treatment of vesico-ureteric reflux. Br J Urol 75:126–131CrossRef Puri P (1995) Ten-year experience with subureteric Teflon (polytetrafluoroethylene) injection (STING) in the treatment of vesico-ureteric reflux. Br J Urol 75:126–131CrossRef
9.
go back to reference Puri P, Ninan GK, Surana R (1995) Subureteric Teflon injection. Results of a European survey. Eur Urol 27:71–75CrossRef Puri P, Ninan GK, Surana R (1995) Subureteric Teflon injection. Results of a European survey. Eur Urol 27:71–75CrossRef
10.
go back to reference Moran Penco JM, Fraile AG, Alarcon JR, Merino FG, Vela D, Rodriguez SS, Brantot AA (2004) Evolution of the treatment of vesicoureteral reflux in Spain. J Urol 170:834–837CrossRef Moran Penco JM, Fraile AG, Alarcon JR, Merino FG, Vela D, Rodriguez SS, Brantot AA (2004) Evolution of the treatment of vesicoureteral reflux in Spain. J Urol 170:834–837CrossRef
11.
go back to reference Puri P (2000) Endoscopic correction of vesicoureteral reflux. Curr Opin Urol 10:593–597CrossRef Puri P (2000) Endoscopic correction of vesicoureteral reflux. Curr Opin Urol 10:593–597CrossRef
12.
go back to reference Capozza N, Patricolo M, Lais A, Matarazzo E, Caione P (2001) Endoscopic treatment of vesico-ureteral reflux: twelve years’ experience. Urol Int 67:228–231CrossRef Capozza N, Patricolo M, Lais A, Matarazzo E, Caione P (2001) Endoscopic treatment of vesico-ureteral reflux: twelve years’ experience. Urol Int 67:228–231CrossRef
13.
go back to reference Malizia A, Reiman H, Myers R (1984) Migration and granulomatous reaction after periureteral injection of polytef. JAMA 24:3277–3279CrossRef Malizia A, Reiman H, Myers R (1984) Migration and granulomatous reaction after periureteral injection of polytef. JAMA 24:3277–3279CrossRef
14.
go back to reference Simsek F, Yucel S, Aktas M, Turkeri L (2004) Ordinary glass spheres as an alternative injectable material for endoscopic correction of vesicoureteral reflux. J Urol 171:1282–1285CrossRef Simsek F, Yucel S, Aktas M, Turkeri L (2004) Ordinary glass spheres as an alternative injectable material for endoscopic correction of vesicoureteral reflux. J Urol 171:1282–1285CrossRef
15.
go back to reference Puri P, Cacio S, Lakshmandass G, Colhoun E (1998) Urinary tract infection and renal damage in sibling vesicoureteral reflux. J Urol 160:1028–1230CrossRef Puri P, Cacio S, Lakshmandass G, Colhoun E (1998) Urinary tract infection and renal damage in sibling vesicoureteral reflux. J Urol 160:1028–1230CrossRef
16.
go back to reference Yoneda A, Cascio S, Uoe T, Chertin B, Puri P (2002) Risk factors for development of renal parenchymal damage in familial vesicoureteral reflux. J Urol 168:1704–1707CrossRef Yoneda A, Cascio S, Uoe T, Chertin B, Puri P (2002) Risk factors for development of renal parenchymal damage in familial vesicoureteral reflux. J Urol 168:1704–1707CrossRef
17.
go back to reference Blake NS, O’Connell E (1989) Endoscopic correction of vesico-ureteric reflux by subureteric Teflon injection: follow-up ultrasound and voiding cystography. Br J Radiol 62:443–446CrossRef Blake NS, O’Connell E (1989) Endoscopic correction of vesico-ureteric reflux by subureteric Teflon injection: follow-up ultrasound and voiding cystography. Br J Radiol 62:443–446CrossRef
Metadata
Title
Role of the Teflon deposit in the recurrence of vesicoureteral reflux
Authors
Zsolt Oberritter
Reka Somogyi
Zsolt Juhasz
Andrew B. Pinter
Publication date
01-05-2008
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 5/2008
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-007-0725-6

Other articles of this Issue 5/2008

Pediatric Nephrology 5/2008 Go to the issue